Heart disease remains the leading cause of death as risk factors surge, AHA 2025 report finds
U.S. deaths from heart disease climbed in 2022, with nearly 942,000 cardiovascular fatalities as rising obesity, high blood pressure and diabetes drive concern, the American Heart Association reports.
The American Heart Association’s 2025 Heart Disease and Stroke Statistics, published today in Circulation, shows heart disease and stroke continue to claim more lives than any other causes in the United States. The report finds 941,652 cardiovascular-related deaths in 2022 and details sharply rising risk factors — including obesity, hypertension and diabetes — that threaten to reverse decades of progress against heart disease.
U.S. cardiovascular fatalities and trend lines
The report records 941,652 deaths attributable to cardiovascular disease in 2022, an increase of more than 10,000 from 2021’s total. Measured on an age-adjusted basis, the CVD death rate fell slightly to 224.3 per 100,000 people from 233.3 in 2021, indicating shifting population dynamics despite higher absolute numbers.
Researchers note the overall toll appears to be stabilizing after a marked pandemic-era rise, with age-adjusted death rates dropping for nine of the ten leading causes of death. Kidney disease was the only leading cause to show an uptick in age-adjusted mortality, rising by 1.5 percent.
Prevalence of major risk factors
The update highlights widespread increases in conditions that drive heart disease, with nearly 47 percent of U.S. adults now categorized as having high blood pressure. More than 72 percent of adults have an unhealthy weight, defined as BMI of 25 or higher, and almost 42 percent meet the clinical threshold for obesity.
Diabetes and prediabetes are also pervasive, affecting about 57 percent of U.S. adults according to the statistical summary. The report’s writing committee emphasizes that these risk factors cluster together and amplify one another, creating what the AHA describes as cardiovascular-kidney-metabolic (CKM) interconnections.
Disparities by sex and race/ethnicity
The AHA report details striking disparities across demographic groups, with Black women experiencing the highest recorded obesity prevalence at 57.9 percent compared with 14.5 percent among Asian women. Diabetes prevalence was highest among Hispanic men at 14.5 percent, and high blood pressure was most common among Black women at 58.4 percent.
Authors stress that such variation will require targeted public health strategies rather than one-size-fits-all solutions. Leaders on the report’s committees warn that equitable access to prevention and treatment is critical to reduce these gaps and lower the national burden of heart disease.
Rising impact on children and global weight trends
The report draws attention to alarming trends in younger populations, noting that up to 40 percent of U.S. children have an unhealthy weight and roughly 20 percent meet the criteria for childhood obesity. Globally, nearly 60 percent of adults carry excess weight, underscoring a worldwide shift in metabolic risk.
Analysts calculate that excess weight contributes to as many as 1,300 additional deaths per day in the United States — nearly half a million deaths per year — and can reduce life expectancy by as much as 2.4 years. The report cautions that the mortality impact of excess weight now exceeds that of smoking in absolute terms.
Smoking, cholesterol and future projections
There are some positive signals: smoking rates have fallen substantially since the 1960s, and current cigarette use among U.S. adults is reported at about 11.5 percent. Youth tobacco and e-cigarette use also declined between 2022 and 2023, while age-adjusted cholesterol levels have improved thanks to prevention efforts and clinical management.
Despite these gains, the AHA’s forecasting work warns that if current trends continue, hypertension and obesity could each affect more than 180 million U.S. adults by 2050, and diabetes prevalence could exceed 80 million. The group projects a roughly 300 percent increase in health care costs tied to cardiovascular disease by mid-century.
Calls for prevention, access and tailored interventions
AHA volunteer leaders emphasize that medical innovation alone will not solve the crisis; broad prevention policies and equitable delivery of care are necessary. They urge investments in early prevention, community-level interventions, and policies that address social determinants of health to curb the rise in risk factors.
The report’s authors also point to emerging obesity therapies and improved clinical tools as important elements of a multipronged response, but they caution that new treatments must be affordable and accessible to populations at greatest risk. The statistical update was prepared by a volunteer writing group for the American Heart Association’s Council on Epidemiology and Prevention and related committees.
Ending the trend will require coordinated action across public health, clinical care and policy to reduce high blood pressure, obesity and diabetes, particularly in the communities most affected.
